Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

522 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Killer-cell immunoglobulin-like receptor gene profile predicts good molecular response to dasatinib therapy in chronic myeloid leukemia.
Kreutzman A, Jaatinen T, Greco D, Vakkila E, Richter J, Ekblom M, Hjorth-Hansen H, Stenke L, Melo T, Paquette R, Seggewiss-Bernhardt R, Guerci-Bresler A, Talbot A, Cayuela JM, Mahon FX, Porkka K, Lipton J, Partanen J, Rousselot P, Mustjoki S. Kreutzman A, et al. Among authors: melo t. Exp Hematol. 2012 Nov;40(11):906-913.e1. doi: 10.1016/j.exphem.2012.07.007. Epub 2012 Jul 25. Exp Hematol. 2012. PMID: 22842045 Free article.
Rapid mobilization of cytotoxic lymphocytes induced by dasatinib therapy.
Mustjoki S, Auvinen K, Kreutzman A, Rousselot P, Hernesniemi S, Melo T, Lahesmaa-Korpinen AM, Hautaniemi S, Bouchet S, Molimard M, Smykla R, Lee FY, Vakkila J, Jalkanen S, Salmi M, Porkka K. Mustjoki S, et al. Among authors: melo t. Leukemia. 2013 Apr;27(4):914-24. doi: 10.1038/leu.2012.348. Epub 2012 Nov 29. Leukemia. 2013. PMID: 23192016
Recommendations from a Portuguese Expert Group for Discontinuation of Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia Patients in Clinical Practice.
Almeida A, Pierdomenico F, Guerrero BP, Saraiva F, Montalvão A, Coutinho J, Mariz M, Melo T, Santos MJ, Pereira A, Cerveira N. Almeida A, et al. Among authors: melo t. Acta Med Port. 2019 Aug 1;32(7-8):550-557. doi: 10.20344/amp.11823. Epub 2019 Aug 1. Acta Med Port. 2019. PMID: 31445538 Free article.
New prospects for the management of cardiovascular effects of tyrosine kinase inhibitors in patients with chronic myeloid leukemia.
Almeida AG, Almeida A, Melo T, Guerra L, Lopes L, Ribeiro P, Duarte M, Mota A, Fontes-Carvalho R. Almeida AG, et al. Among authors: melo t. Rev Port Cardiol (Engl Ed). 2019 Jan;38(1):1-9. doi: 10.1016/j.repc.2017.10.013. Epub 2019 Jan 24. Rev Port Cardiol (Engl Ed). 2019. PMID: 30686651 Free article. Review. English, Portuguese.
[Comas in the emergency room of a central hospital].
De Mendonça A, Melo TP, Crespo M, Ferro JM. De Mendonça A, et al. Among authors: melo tp. Acta Med Port. 1992 Sep;5(8):429-32. Acta Med Port. 1992. PMID: 1442192 Free article. Portuguese.
[Nimodipine in subarachnoid hemorrhage].
Ferro JM, Canhão P, Melo TP, Campos JG, Trindade A, Antunes JL. Ferro JM, et al. Among authors: melo tp. Acta Med Port. 1991 May-Jun;4(3):138-40. Acta Med Port. 1991. PMID: 1950663 Free article. Portuguese.
522 results